Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Agios Pharmaceuticals, Inc, and AstraZeneca.

Cancer Summaries and Commentaries™: Update from Barcelona: Advances in the Treatment of Gastrointestinal Cancers: Cholangiocarcinoma and Pancreatic Cancer

Release Date: December 20, 2019
Expiration Date: December 20, 2020
Media: Internet - based

Activity Overview

This online activity is designed to update clinicians on data presented at the European Society for Medical Oncology Congress 2019 (ESMO 2019), held September 27 to October 1, 2019, in Barcelona, Spain. This Cancer Summaries and Commentaries™ continuing medical education (CME) activity facilitates critical assessment and clinical integration of new evidence, when appropriate. The activity reviews 4 abstracts from ESMO 2019 that focus on cholangiocarcinoma and pancreatic cancer. For each abstract, a text summary of key clinical data is accompanied by perspectives from expert thought leaders who provide insights into how clinicians can apply these findings to their clinical practice to improve patient care.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Agios Pharmaceuticals, Inc, and AstraZeneca.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Videos” will be available for your reference.
  • In order to receive a CME Certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME Certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical oncologists and fellows who treat patients with gastrointestinal (GI) cancers. Gastroenterologists, surgical oncologists, radiation oncologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of GI cancers are invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Outline methods that allow for optimized characterization of tumor biology among patients with GI cancers
  • Explain the study design, rationale, and results of recent clinical trials evaluating novel strategies for the treatment of GI cancers
  • Consider recent evidence in the context of evolving treatment paradigms in the field of GI cancers

Faculty, Staff, and Planners’ Disclosures


Eric Collisson, MD
Eric Collisson, MD
Associate Professor
Division of Hematology/Oncology, Department of Medicine
UC San Francisco School of Medicine
San Francisco, CA

Disclosures: Grant Research Support: Merck Kga, Astra Zeneca, Senti Bio; Shareholder: Guardant health, clara health, illumina, Tatara Therapeutics

Shubham Pant, MD
Shubham Pant, MD
Associate Director for Early Phase Drug Development,
Sheikh Ahmed Center for Pancreatic Cancer Research,
UTMD Anderson Cancer Center, Houston, TX
Associate Professor, Investigational Cancer Therapeutics Division of Cancer Medicine
UTMD Anderson Cancer Center, Houston, TX
Associate Professor, Gastrointestinal GI Medical Oncology,
Division of Cancer Medicine
UTMD Anderson Cancer Center, Houston, TX

Disclosures: Consultant: Tyme. Inc., and 4-D Pharmacy

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By